Cited by 191Genomics and Chromatin DynamicsEpigenetics and DNA MethylationAdipose Tissue and Metabolism

MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis

Open access
Lai, Binbin, Lee, Ji-Eun, Jang, Younghoon, Wang, Lifeng, Peng, Weiqun, Ge, Kai·2017·Nucleic Acids Research

Abstract

Histone H3K4me1/2 methyltransferases MLL3/MLL4 and H3K27 acetyltransferases CBP/p300 are major enhancer epigenomic writers. To understand how these epigenomic writers orchestrate enhancer landscapes in cell differentiation, we have profiled genomic binding of MLL4, CBP, lineage-determining transcription factors (EBF2, C/EBPβ, C/EBPα, PPARγ), coactivator MED1, RNA polymerase II, as well as epigenome (H3K4me1/2/3, H3K9me2, H3K27me3, H3K36me3, H3K27ac), transcriptome and chromatin opening during adipogenesis of immortalized preadipocytes derived from mouse brown adipose tissue (BAT). We show that MLL4 and CBP drive the dynamic enhancer epigenome, which correlates with the dynamic transcriptome. MLL3/MLL4 are required for CBP/p300 binding on enhancers activated during adipogenesis. Further, MLL4 and CBP identify super-enhancers (SEs) of adipogenesis and that MLL3/MLL4 are required for SE formation. Finally, in brown adipocytes differentiated in culture, MLL4 identifies primed SEs of genes fully activated in BAT such as Ucp1. Comparison of MLL4-defined SEs in brown and white adipogenesis identifies brown-specific SE-associated genes that could be involved in BAT functions. These results establish MLL3/MLL4 and CBP/p300 as master enhancer epigenomic writers and suggest that enhancer-priming by MLL3/MLL4 followed by enhancer-activation by CBP/p300 sequentially shape dynamic enhancer landscapes during cell differentiation. Our data also provide a rich resource for understanding epigenomic regulation of brown adipogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkx234

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies showed that the MLL4 complex recruits and activates p300 activity, involving UTX, at enhancers, resulting not only in methylation at H3K4 but also acetylation on H3K27 at target chromatin.

    “recent studies showed that the MLL4 complex recruits and activates p300 activity, involving UTX, at enhancers, resulting not only in methylation at H3K4 but also acetylation on H3K27 at target chromatin41,61.”

    From HNF4A guides the MLL4 complex to establish and maintain H3K4me1 at gene regulatory elements (2024) · cites this paper as [61]

    The Discussion (page unavailable) says MLL3/MLL4 facilitate CBP/p300 binding at enhancers and links the proteins to H3K4 methylation and H3K27 acetylation. The Results (Figure 5F; page unavailable) show that MLL4 interacts with UTX, but the paper does not establish that UTX mediates CBP/p300 recruitment or that the MLL4 complex activates p300 enzymatic activity. The Discussion says the binding mechanism remains unknown. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. [3]Calo E., Wysocka J. Modification of enhancer chromatin: what, how, and why?. Mol. Cell. 2013; 49: 825– 837. 23473601 PMC3857148
  2. [4]Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U.S.A. 2010; 107: 21931– 21936. 21106759 PMC3003124
  3. [5]Lee J.E., Wang C., Xu S., Cho Y.W., Wang L., Feng X., Baldridge A., Sartorelli V., Zhuang L., Peng W. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. Elife. 2013; 2: e01503. 24368734 PMC3869375
  4. [6]Wang C., Lee J.E., Lai B., Macfarlan T.S., Xu S., Zhuang L., Liu C., Peng W., Ge K. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition. Proc. Natl. Acad. Sci. U.S.A. 2016; 113: 11871– 11876. 27698142 PMC5081576
  5. [7]Jin Q., Yu L.-R., Wang L., Zhang Z., Kasper L.H., Lee J.-E., Wang C., Brindle P.K., Dent S.Y., Ge K. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J. 2011; 30: 249– 262. 21131905 PMC3025463
  6. [8]Visel A., Blow M.J., Li Z., Zhang T., Akiyama J.A., Holt A., Plajzer-Frick I., Shoukry M., Wright C., Chen F. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature. 2009; 457: 854– 858. 19212405 PMC2745234
  7. [9]Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006; 4: 263– 273. 17011499 PMC1958996
  8. [11]Siersbaek R., Nielsen R., John S., Sung M.H., Baek S., Loft A., Hager G.L., Mandrup S. Extensive chromatin remodelling and establishment of transcription factor ‘hotspots’ during early adipogenesis. EMBO J. 2011; 30: 1459– 1472. 21427703 PMC3102274
  9. [12]Park Y.K., Wang L., Giampietro A., Lai B., Lee J.E., Ge K. Distinct roles of transcription factors KLF4, Krox20, and peroxisome proliferator-activated receptor γ in adipogenesis. Mol. Cell. Biol. 2017; 37, doi:10.1128/MCB.00554-16. PMC5214852 27777310 · DOI
  10. [13]Lefterova M.I., Haakonsson A.K., Lazar M.A., Mandrup S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol. Metab. 2014; 25: 293– 302. 24793638 PMC4104504
  11. [14]Ge K. Epigenetic regulation of adipogenesis by histone methylation. Biochim. Biophys. Acta. 2012; 1819: 727– 732. 22240386 PMC3328666
  12. [15]Lee J.E., Ge K. Transcriptional and epigenetic regulation of PPARgamma expression during adipogenesis. Cell Biosci. 2014; 4, doi:10.1186/2045-3701-4-29. PMC4046494 24904744 · DOI
  13. [16]Takahashi N., Kawada T., Yamamoto T., Goto T., Taimatsu A., Aoki N., Kawasaki H., Taira K., Yokoyama K.K., Kamei Y. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2002; 277: 16906– 16912. 11884404
  14. [18]Rosen E.D., Spiegelman B.M. What we talk about when we talk about fat. Cell. 2014; 156: 20– 44. 24439368 PMC3934003
  15. [19]Seale P., Kajimura S., Yang W., Chin S., Rohas L.M., Uldry M., Tavernier G., Langin D., Spiegelman B.M. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 2007; 6: 38– 51. 17618855 PMC2564846
  16. [20]Rajakumari S., Wu J., Ishibashi J., Lim H.W., Giang A.H., Won K.J., Reed R.R., Seale P. EBF2 determines and maintains brown adipocyte identity. Cell Metab. 2013; 17: 562– 574. 23499423 PMC3622114
  17. [21]Hong S., Cho Y.W., Yu L.-R., Yu H., Veenstra T.D., Ge K. Identification of JmjC domain-containing UTX and JMJD2 as histone H3 lysine 27 demethylases. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 18439– 18444. 18003914 PMC2141795
  18. [22]Jang Y., Wang C., Zhuang L., Liu C., Ge K. H3K4 methyltransferase activity is required for MLL4 protein stability. J. Mol. Biol. 2016; doi:10.1016/j.jmb.2016.12.016. PMC5474351 28013028 · DOI
  19. [23]Wang L., Jin Q., Lee J.E., Su I.H., Ge K. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc. Natl. Acad. Sci. U.S.A. 2010; 107: 7317– 7322. 20368440 PMC2867706
  20. [24]Giresi P.G., Lieb J.D. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods. 2009; 48: 233– 239. 19303047 PMC2710428
  21. [25]Zang C., Schones D.E., Zeng C., Cui K., Zhao K., Peng W. A clustering approach for identification of enriched domains from histone modification ChIP-seq data. Bioinformatics. 2009; 25: 1952– 1958. 19505939 PMC2732366
  22. [26]Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-seq. Bioinformatics. 2009; 25: 1105– 1111. 19289445 PMC2672628
  23. [28]Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009; 4: 44– 57. 19131956
  24. [29]Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013; 153: 307– 319. 23582322 PMC3653129
  25. [30]Yue F., Cheng Y., Breschi A., Vierstra J., Wu W., Ryba T., Sandstrom R., Ma Z., Daves C., Pope B.D. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014; 515: 355– 364. 25409824 PMC4266106
  26. [31]Wang L., Xu S., Lee J.-E., Baldridge A., Grullon S., Peng W., Ge K. Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis. EMBO J. 2013; 32: 45– 59. 23178591 PMC3545301
  27. [32]Wamstad J.A., Alexander J.M., Truty R.M., Shrikumar A., Li F., Eilertson K.E., Ding H., Wylie J.N., Pico A.R., Capra J.A. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell. 2012; 151: 206– 220. 22981692 PMC3462286
  28. [33]Bonn S., Zinzen R.P., Girardot C., Gustafson E.H., Perez-Gonzalez A., Delhomme N., Ghavi-Helm Y., Wilczynski B., Riddell A., Furlong E.E. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat. Genet. 2012; 44: 148– 156. 22231485
  29. [34]ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489: 57– 74. 22955616 PMC3439153
  30. [35]Mikkelsen T.S., Xu Z., Zhang X., Wang L., Gimble J.M., Lander E.S., Rosen E.D. Comparative epigenomic analysis of murine and human adipogenesis. Cell. 2010; 143: 156– 169. 20887899 PMC2950833
  31. [38]Witte S., Bradley A., Enright A.J., Muljo S.A. High-density P300 enhancers control cell state transitions. BMC Genomics. 2015; 16, doi:10.1186/s12864-015-1905-6. PMC4636788 26546038 · DOI
  32. [39]Brunmeir R., Wu J., Peng X., Kim S.Y., Julien S.G., Zhang Q., Xie W., Xu F. Comparative transcriptomic and epigenomic analyses reveal new regulators of murine brown adipogenesis. PLoS Genet. 2016; 12: e1006474. 27923061 PMC5140063
  33. [40]Zhou P., Robles-Murguia M., Mathew D., Duffield G.E. Impaired thermogenesis and a molecular signature for brown adipose tissue in Id2 null mice. J. Diabetes Res. 2016; 2016, doi:10.1155/2016/6785948. PMC4842059 27144179 · DOI

Cited by

Sorted by citations

Authors
Lai, B., Lee, J.-E., Jang, Y., Wang, L., Peng, W., & Ge, K.
Affiliations
  • National Institutes of Health (US)
  • George Washington University (US)
Corresponding author
  • Lai, Binbin
  • Lee, Ji-Eun
  • Peng, Weiqun
  • Ge, Kai
Venue
Nucleic Acids Research
Published
2017-04-08
Volume
45
Issue
11
Pages
6388-6403
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2604847558
Cited by
191
References
7
Citations by year
2026: 17 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 22 · 2020: 27 · 2019: 14 · 2018: 21 · 2017: 3
FWCI
7.26
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Nucleic Acids Research (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (R21AI113806)
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
CBP/p300, super-enhancers, brown adipogenesis, H3K4 methylation, H3K27 acetylation, MED1, transcriptional coactivator, UCP1, preadipocytes, chromatin opening, cell differentiation
MeSH terms
Animals, Adipose Tissue, Brown, Cells, Cultured, DNA-Binding Proteins, Enhancer Elements, Genetic, Mice, Transgenic, Protein Binding, Histone-Lysine N-Methyltransferase, Transcriptional Activation, Adipogenesis, E1A-Associated p300 Protein, CREB-Binding Protein, Adipocytes, Brown, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review